自主准无载体协调纳米疗法用于瘤微环境调制和增强化学动态瘤治疗
Zhongxiong Fan1, Fukai Zhu2, Feng Wu3
1School of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Colloids and surfaces. B, Biointerfaces
|July 29, 2025
概括
这项研究引入了一种新的纳米疗法 (PEM-CuII-MET),通过增加活性氧物种 (ROS) 和克服瘤微环境挑战,如缺氧和谷氨来增强癌症治疗. 它提高了化学动力学疗法 (CDT) 的疗效.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 基于活性氧物种 (ROS) 的癌症治疗是有前途的,但由于药物递送效率低和瘤微环境 (TME) 因素 (如缺氧和高谷氨 (GSH) 等) 受到限制.
- 开发向纳米治疗药物对于克服这些局限性和提高抗瘤疗效至关重要.
研究的目的:
- 设计和评估一种无载体,自我向的纳米疗法 (PEM-CuII-MET),用于增强ROS生成和改进化学动力学疗法 (CDT).
- 为了应对药物输送,瘤缺氧和TME中的GSH水平的挑战.
主要方法:
- 佩米特雷克斯 (PEM),铜离子 (CuII) 和甲胺 (MET) 的协调驱动的自我组装形成了PEM-CuII-MET (PCM) 纳米疗法.
- 利用叶酸受体向和TME刺激 (溶酶体酸,GSH) 进行向积累和药物释放.
- 调查MET对氧气消耗的影响,通过NADPH氧化酶 (NOX) 和超氧化物脱酶 (SOD) 生成ROS,以及CuII介导的GSH耗尽.
主要成果:
- PCM 证明了有效的瘤积累和细胞内化,随后是药物快速释放.
- 释放的MET有效地通过抑制线粒体呼吸来缓解瘤缺氧,从而导致富含氧气的环境.
- 该纳米疗法成功地提高了过氧化 (H2O2) 水平,并促进了GSH的耗尽,显著提高了ROS积累,从而提高了CDT的疗效.
结论:
- 开发的纳米疗法 (PCM) 通过多种机制有效地放大了ROS生成.
- 通过PCM,可以重编程TME并显著提高化学动力瘤治疗的疗效.
相关概念视频
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


